Governance bioMérieux

BIM

FR0013280286

Medical Equipment, Supplies & Distribution

Real-time Euronext Paris Other stock markets 14:18:48 13/03/2026 GMT			5-day change	1st Jan Change
94.85 ^EUR	+0.53%		-0.58%	-14.01%

03-05	TP ICAP Midcap Downgrades BioMérieux to Hold, Cuts PT	MT
03-04	BioMérieux S.A. announces Annual dividend, payable on June 11, 2026	CI

Executive Committee: bioMérieux

Manager

Positions heldSince

Pierre Boulud

54 year

Chief Executive Officer

30/06/2023

Audrey Dauvet

General Counsel

31/12/2022

Charles Cooper

Chief Tech/Sci/R&D Officer

01/01/2024

Jennifer Zinn

Chief Tech/Sci/R&D Officer

31/07/2023

Guillaume Bouhours

49 year

Chief Tech/Sci/R&D Officer	28/02/2018
Director of Finance/CFO	28/02/2018

Valérie Leyldé

Human Resources Officer	-
Public Communications Contact	-

Composition of the Board of Directors: bioMérieux

Director

CommitteesSince

Alexandre Mérieux

52 year

Compensation Committee Chair

25/04/2018

Viviane Monges

61 year

Audit Committee Chair	28/06/2021
Governance Committee	10/06/2021
Nominating Committee	10/06/2021

Philippe Archinard

65 year

Audit Committee	22/06/2023
Compensation Committee	22/06/2023
Nominating Committee	22/06/2023

Fanny Letier

47 year

Audit Committee
Compensation Committee Chair	29/06/2017
HR Committee Chair	29/06/2017

Benoît Ribadeau-Dumas

54 year

Compensation Committee	12/04/2023
Governance Committee	06/05/2024
Nominating Committee	06/05/2024

Marie-Hélène Habert-Dassault

60 year

Compensation Committee	14/11/2012
HR Committee	14/11/2012

Sylvain Orenga

Compensation Committee	23/05/2022
Nominating Committee	22/05/2022

Jean-Luc Bélingard

76 year

Compensation Committee	17/12/2017
HR Committee	17/12/2017

Harold Y. H. Boël

61 year

Audit Committee Chair

14/11/2012

Marie-Paule Kieny

70 year

Director/Board Member	27/08/2017
Independent Dir/Board Member	27/08/2017

Latest Appointments: bioMérieux

02-27	BioMérieux, Saint-Gobain, SRP Groupe... Stocks to Watch Today in Paris
02-26	Bonduelle, Technip Energies, Vallourec, Viridien... Stocks to Watch Tomorrow in Paris
30/06/24	Aurobac Therapeutics, founded by Boehringer Ingelheim, bioMerieux and Evotec, Names Scientific Advisory Board	CI
16/01/24	BioMérieux appoints two new members to its Executive Committee
28/06/23	BioMérieux: new Director of Clinical Operations
28/02/18	BioMérieux S.A Recommends Dividend, Payable on May 17, 2018, Announces Executive Changes	CI
15/12/17	BioMérieux Announces Management Changes	CI

More news

Former Officers and Directors: bioMérieux

Insider

Positions held

SinceUntil

François Lacoste

Chief Tech/Sci/R&D Officer

29/02/2024

Mark Miller

Chief Tech/Sci/R&D Officer

01/11/2012

01/01/2024

Agnès Lemarchand

Director/Board Member	27/05/2014	22/03/2023
Independent Dir/Board Member	27/05/2014	22/03/2023

Esther Wick

Compliance Officer	31/12/2016	31/08/2022
General Counsel	31/12/2016	31/08/2022

Frédéric Besème

Director/Board Member

16/05/2018

23/05/2022

Sandrine Flory

Corporate Officer/Principal

31/12/2013

31/12/2019

Claire Giraut

Director of Finance/CFO	31/12/2013	27/02/2018
Corporate Officer/Principal	31/08/2013	31/12/2013

Michel Baguenault de Puchesse

Human Resources Officer	31/12/2010	31/12/2015
Public Communications Contact	31/12/2010	31/12/2015
Corporate Secretary	31/12/2010	31/12/2015

Marcello Damiani

Chief Tech/Sci/R&D Officer

31/12/2008

31/12/2014

Philippe Gillet

Director/Board Member	27/05/2014	-
Independent Dir/Board Member	27/05/2014	-

Michel Angé

Director/Board Member	-	27/05/2014
Independent Dir/Board Member	-	27/05/2014

Georges Hibon

Director/Board Member

21/04/2010

31/12/2013

Henri Thomasson

Director of Finance/CFO	21/04/2010	-
General Counsel	21/04/2010	31/12/2013

Manuel Méndez Muñiz

Corporate Officer/Principal

18/05/2010

31/12/2013

Christian Brechot

Director/Board Member

31/12/2011

Eileen C. Pruette

Corporate Officer/Principal

31/12/2011

Gentiane Gorlier

General Counsel	31/12/2003	30/10/2011
Corporate Officer/Principal	31/12/2003	30/10/2011

Stéphane Bancel

Chief Executive Officer

31/12/2006

30/06/2011

Eric Bouvier

Corporate Officer/Principal

21/04/2010

31/03/2011

James P. Whelan

Corporate Officer/Principal

04/01/2011

Philippe Cleuziat

Director/Board Member

05/11/2009

20/04/2010

Mojgan Lefebvre

Chief Tech/Sci/R&D Officer

31/12/2006

31/12/2009

Jean-Fabien Monin

Director of Finance/CFO

30/11/2006

28/02/2009

Richard Ding

Corporate Officer/Principal

31/12/2005

31/12/2007

Jean François Carmier

Corporate Officer/Principal

31/12/2006

Michele Palladino

Director/Board Member	05/07/2004	-
Independent Dir/Board Member	05/07/2004	-
Chief Executive Officer	-	31/12/1992

Benoît Habert

Director/Board Member	21/04/2010	-
Independent Dir/Board Member	15/04/2004	-

Carinne Knoche-Brouillon

Sales & Marketing

31/12/1990

31/12/1994

Stephen Harbin

Chief Tech/Sci/R&D Officer	03/10/2012	-
General Counsel	03/10/2012	-
Corporate Officer/Principal	21/04/2010	03/10/2012

Christine Ginocchio

Chief Tech/Sci/R&D Officer

Dominique Takizawa

Public Communications Contact

16/09/2009

Richard F. Labaudinière

Corporate Officer/Principal

Bernard Gilly

Chief Tech/Sci/R&D Officer

Henri Thomasson

Director/Board Member

Herve Laurent

Public Communications Contact

16/09/2009

Pablo Jordan

Corporate Officer/Principal

Thierry Delair

Corporate Officer/Principal

Nicolas Cartier

Corporate Officer/Principal

James Kropp

Director of Finance/CFO

Jean-Marc Durano

Corporate Officer/Principal

21/04/2010

Isabelle Tongio

Investor Relations Contact

Koren Wolman-Tardy

Public Communications Contact

Stefan Willemsen

General Counsel	-	-
Corporate Officer/Principal	-	-

Thibaut du Fayet

Sales & Marketing

Éric Trappier

Director/Board Member

Erik Jan Zimmer

Corporate Officer/Principal

Bruce Draper

Corporate Officer/Principal

Peter Kaspar

Corporate Officer/Principal

21/04/2010

Thierry Bernard

Corporate Officer/Principal

21/04/2010

Alain Pluquet

Chief Tech/Sci/R&D Officer	-	-
Corporate Officer/Principal	-	-

Jacques de Jong

Chief Tech/Sci/R&D Officer

Alain Mérieux

Director/Board Member	31/12/1962	30/04/2017
Chairman	17/12/2017	-
Founder	31/12/1962	-
Independent Dir/Board Member	31/12/1962	30/04/2017

Age distribution of managers

Parity Men Women

Male	12
Female	7

Of which Executive Committee

Male	3
Female	3

Of which Directors

Male	6
Female	4

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

bioMérieux designs, develops, produces, and sells systems used in clinical practice to diagnose infectious diseases (including HIV, tuberculosis, and respiratory infections), cancers, and cardiovascular pathologies based on a biological sample (blood, saliva, urine, etc.). Net sales break down by sector of application as follows: - medical applications (84.8%): in industry, microbiological testing of samples from finished products, materials during the manufacturing process, or the environment, primarily in the food-processing, pharmaceutical, and cosmetics sectors; - industrial applications (15.2%). The group's diagnostic systems consist of three elements with related services: reagents, instruments (or platforms or analyzers), software, and services. Net sales are distributed geographically as follows: Europe/Middle East/Africa (31.9%), North America (45%), Asia/Pacific (16,5%) and Latin America (6.6%).

Employees

14,451

Sector

Medical Equipment, Supplies & Distribution

Calendar

06-09 - Ex-dividend date - 0.98 EUR

More about the company